--- title: "PegBio Co. (2565) stock listing, news and investor profile" url: "https://aibio.space/companies/pegbio/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "PegBio Co., Ltd. (HKEX: 2565), China. The directory classifies it as Biotechnology. Listing facts, related biotech companies and news on aibio.space." --- 2565 PegBio Co., Ltd. HKEX · China # PegBio Co. (2565) news PegBio Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2565, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest PegBio Co. news We have not published a story on PegBio Co. yet. When there is news, it will appear here. ## PegBio Co. at a glance - **Ticker**: 2565 - **Listing**: HKEX - **Country**: China ### Related companies - [Duality Biotherapeutics](https://aibio.space/companies/duality-biotherapeutics/) HKEX: 9606 - [LongBio Pharma (Suzhou) Co.](https://aibio.space/companies/longbio-pharma-suzhou/) HKEX: 1779 - [Alphamab Oncology](https://aibio.space/companies/alphamab-oncology/) HKEX: 9966 - [Shanghai Obio Technology (Group) Corp.](https://aibio.space/companies/shanghai-obio-technology/) SSE: 688238 - [IMPACT Therapeutics](https://aibio.space/companies/impact-therapeutics/) HKEX: 7630 - [TransThera Sciences (Nanjing).](https://aibio.space/companies/transthera-sciences-nanjing/) HKEX: 2617 - [Hualan Biological Engineering](https://aibio.space/companies/hualan-biological-engineering/) SZSE: 002007 - [Brii Biosciences](https://aibio.space/companies/brii-biosciences/) HKEX: 2137 ### Also on HKEX - [China Biotech Services Holdings](https://aibio.space/companies/china-biotech-services/) 8037 - [Lee's Pharmaceutical Holdings](https://aibio.space/companies/lee-s-pharmaceutical/) 950 - [Regent Pacific Group](https://aibio.space/companies/regent-pacific/) 575 - [Beijing Tong Ren Tang Chinese Medicine Co.](https://aibio.space/companies/beijing-tong-ren-tang-chinese-medicine/) 3613 - [Qyuns Therapeutics Co.](https://aibio.space/companies/qyuns-therapeutics/) 2509 - [Immunotech Biopharm](https://aibio.space/companies/immunotech-biopharm/) 6978 ## Questions about PegBio Co. What is the ticker symbol of PegBio Co.? PegBio Co., Ltd. trades under the ticker 2565 on HKEX. Where is PegBio Co. listed? PegBio Co., Ltd. is listed on HKEX. Which country or territory is PegBio Co. listed under? Our directory records PegBio Co., Ltd. under China. What does PegBio Co. do? Our directory classifies PegBio Co., Ltd. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of PegBio Co.? The ISIN recorded for PegBio Co., Ltd. is CNE100006T44. Does aibio.space cover PegBio Co.? aibio.space lists PegBio Co., Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to PegBio Co.? Companies in our directory listed in the same country and business area as PegBio Co.: Duality Biotherapeutics, LongBio Pharma (Suzhou) Co., Alphamab Oncology, Shanghai Obio Technology (Group) Corp., IMPACT Therapeutics, TransThera Sciences (Nanjing).. ## Investor discussion: PegBio Co. Members talk about PegBio Co. (2565). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at PegBio Co., newest first. Each line links the filing it comes from. 1. 2026-06-01 Financings Share or debt issue: 2025 AGM Circular. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0601/2026060103984.pdf) 2. 2026-03-10 Listings Share consolidation: CHANGE IN BOARD LOT SIZE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0310/2026031001045.pdf) 3. 2025-12-22 Financings Share or debt issue: COMPLETION OF PLACING OF NEW H SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1222/2025122201506.pdf) 4. 2025-12-14 Financings Share or debt issue: PLACING OF NEW H SHARES UNDER GENERAL MANDATE. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/1214/2025121400339.pdf) 5. 2025-05-18 Financings Share or debt issue: GLOBAL OFFERING. [Source](https://www1.hkexnews.hk/listedco/listconews/sehk/2025/0519/2025051900013.pdf) ## Press releases Headlines of PegBio Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-10-23 HKEXnews [NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1023/2026102301397.pdf) 2. 2026-10-23 HKEXnews [(1) PROPOSED REMOVAL OF AUDITOR (2) PROPOSED APPOINTMENT OF AUDITOR (3) PROPOSED CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING AND (4) NOTICE OF THE 2026 FIRST EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/1023/2026102301391.pdf) 3. 2026-09-18 HKEXnews [CHANGE IN USE OF PROCEEDS FROM THE GLOBAL OFFERING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0918/2026091801856.pdf) 4. 2026-09-18 HKEXnews [PROPOSED CHANGE OF AUDITOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0918/2026091801844.pdf) 5. 2026-09-02 HKEXnews [VOLUNTARY ANNOUNCEMENT JOINT R&D COLLABORATION WITH SN BIOSCIENCE ADVANCING THE LONG-ACTING DEVELOPMENT OF THREE NEXT-GENERATION INNOVATIVE PEPTIDE CANDIDATES FOR METABOLIC DISEASES, INCLUDING APGP6](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0902/2026090201330.pdf) 6. 2026-08-25 HKEXnews [ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED JUNE 30, 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0825/2026082500358.pdf) 7. 2026-07-22 HKEXnews [VOLUNTARY ANNOUNCEMENT ISSUANCE OF THE FIRST BATCH OF COMMERCIAL PRESCRIPTIONS OF PAIDAKANG NATIONWIDE AND SATISFACTION OF THE CONDITIONS FOR THE SECOND ROYALTY PAYMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0722/2026072200734.pdf) 8. 2026-07-10 HKEXnews [VOLUNTARY ANNOUNCEMENT COLLABORATION WITH NASDAQ-LISTED RANI THERAPEUTICS TO ADVANCE ORAL DELIVERY OF MULTIPLE INNOVATIVE METABOLIC ASSETS](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0710/2026071000029.pdf) 9. 2026-06-29 HKEXnews [VOLUNTARY ANNOUNCEMENT CORE PRODUCT VISEPEGENATIDE INJECTION PASSED THE PRELIMINARY REVIEW IN ACCORDANCE WITH THE 2026 NATIONAL REIMBURSEMENT DRUG LIST ADJUSTMENT](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0629/2026062901263.pdf) 10. 2026-06-26 HKEXnews [COMPLETION OF THE H SHARE FULL CIRCULATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0626/2026062600231.pdf) 11. 2026-06-24 HKEXnews [ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0624/2026062401122.pdf) 12. 2026-06-24 HKEXnews [(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON WEDNESDAY, JUNE 24, 2026; (2) APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR AND CHANGE OF BOARD COMMITTEE MEMBERS; (3) RE-COMPLIANCE WITH LISTING RULES; AND (4) AMENDMENTS TO THE ARTICLES OF ASSOCIATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0624/2026062401106.pdf) 13. 2026-06-05 HKEXnews [VOLUNTARY ANNOUNCEMENT PEGBIO RECEIVES FIRST ROYALTY PAYMENT OF HK$61 MILLION FROM TENRY PHARMACEUTICAL FOR VISEPEGENATIDE COMMERCIALIZATION COLLABORATION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0605/2026060501172.pdf) 14. 2026-06-01 HKEXnews [NOTICE OF THE 2025 ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0601/2026060104002.pdf) 15. 2026-06-01 HKEXnews [2025 AGM Circular](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0601/2026060103984.pdf) 16. 2026-06-01 HKEXnews [VOLUNTARY ANNOUNCEMENT CR059 ACCEPTED BY EASD 2026 AND SELECTED FOR THE ORAL DISCUSSION PRESENTATION SESSION](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0601/2026060102894.pdf) 17. 2026-05-28 HKEXnews [INSIDE INFORMATION ANNOUNCEMENT VISEPEGENATIDE INJECTION INCLUDED IN THE PUBLICATION OF SUPPLEMENTAL DRUG INFORMATION FOR THE SECOND BATCH OF REFERENCE DRUG PRE-COMMUNICATION IN 2026](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0528/2026052801254.pdf) 18. 2026-05-19 HKEXnews [(1) RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTOR; (2) PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR; AND (3) NON-COMPLIANCE WITH LISTING RULES](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0519/2026051901089.pdf) 19. 2026-04-28 HKEXnews [VOLUNTARY ANNOUNCEMENT NOTICE ABOUT VOLUNTARY EXTENSION OF LOCK-UP PERIOD GIVEN BY A CORNERSTONE INVESTOR](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0428/2026042802517.pdf) 20. 2026-04-09 HKEXnews [INSIDE INFORMATION ISSUANCE OF FILING NOTICE BY THE CSRC FOR THE H SHARE FULL CIRCULATION APPLICATION BY THE COMPANY](https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0409/2026040901685.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:2565 on TradingView](https://www.tradingview.com/symbols/HKEX-2565/). ## Listing details PegBio Co., Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 2565, recorded under China. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: PegBio Co., Ltd. - **Ticker**: 2565 - **Listing**: HKEX - **Country or territory**: China - **Business scope**: Biotechnology - **ISIN**: CNE100006T44 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-2565/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/pegbio/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "PegBio Co. (2565) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/pegbio/